NMR Experiment |
---|
Experiment | Type | Sample Contents | Solvent | Ionic Strength | pH | Pressure | Temperature (K) | Spectrometer |
---|
1 | 2D 1H-15N HSQC | 0.6 mM [U-98% 15N] GABARAPL-1, 0.9 mM NBR1-LIR, 50 mM sodium phosphate, 100 mM sodium chloride, 4.6 mM sodium azide, 1 mM protease inhibitor cocktail, 0.3 mM DSS | 95% H2O/5% D2O | 0.1 | 7.0 | ambient | 298 | |
2 | 2D 1H-15N HSQC | 0.9 mM GABARAPL-1, 0.6 mM [U-98% 15N] NBR1-LIR, 50 mM sodium phosphate, 100 mM sodium chloride, 4.6 mM sodium azide, 1 mM protease inhibitor cocktail, 0.3 mM DSS | 95% H2O/5% D2O | 0.1 | 7.0 | ambient | 298 | |
3 | 2D 1H-13C HSQC | 0.6 mM [U-98% 13C; U-98% 15N] GABARAPL-1, 0.9 mM NBR1-LIR, 50 mM sodium phosphate, 100 mM sodium chloride, 4.6 mM sodium azide, 1 mM protease inhibitor cocktail, 0.3 mM DSS | 95% H2O/5% D2O | 0.1 | 7.0 | ambient | 298 | |
4 | 2D 1H-13C HSQC aliphatic | 0.9 mM GABARAPL-1, 0.6 mM [U-98% 13C; U-98% 15N] NBR1-LIR, 50 mM sodium phosphate, 100 mM sodium chloride, 4.6 mM sodium azide, 1 mM protease inhibitor cocktail, 0.3 mM DSS | 95% H2O/5% D2O | 0.1 | 7.0 | ambient | 298 | |
5 | 2D 1H-13C HSQC aromatic | 0.9 mM GABARAPL-1, 0.6 mM [U-98% 13C; U-98% 15N] NBR1-LIR, 50 mM sodium phosphate, 100 mM sodium chloride, 4.6 mM sodium azide, 1 mM protease inhibitor cocktail, 0.3 mM DSS | 95% H2O/5% D2O | 0.1 | 7.0 | ambient | 298 | |
6 | 2D 1H-13C HSQC | 0.9 mM GABARAPL-1, 0.6 mM [U-98% 13C; U-98% 15N] NBR1-LIR, 50 mM sodium phosphate, 100 mM sodium chloride, 4.6 mM sodium azide, 1 mM protease inhibitor cocktail, 0.3 mM DSS | 95% H2O/5% D2O | 0.1 | 7.0 | ambient | 298 | |
7 | 3D HNCO | 0.6 mM [U-98% 13C; U-98% 15N] GABARAPL-1, 0.9 mM NBR1-LIR, 50 mM sodium phosphate, 100 mM sodium chloride, 4.6 mM sodium azide, 1 mM protease inhibitor cocktail, 0.3 mM DSS | 95% H2O/5% D2O | 0.1 | 7.0 | ambient | 298 | |
8 | 3D HN(CA)CO | 0.6 mM [U-98% 13C; U-98% 15N] GABARAPL-1, 0.9 mM NBR1-LIR, 50 mM sodium phosphate, 100 mM sodium chloride, 4.6 mM sodium azide, 1 mM protease inhibitor cocktail, 0.3 mM DSS | 95% H2O/5% D2O | 0.1 | 7.0 | ambient | 298 | |
9 | 3D HNCA | 0.6 mM [U-98% 13C; U-98% 15N] GABARAPL-1, 0.9 mM NBR1-LIR, 50 mM sodium phosphate, 100 mM sodium chloride, 4.6 mM sodium azide, 1 mM protease inhibitor cocktail, 0.3 mM DSS | 95% H2O/5% D2O | 0.1 | 7.0 | ambient | 298 | |
10 | 3D HNCACB | 0.6 mM [U-98% 13C; U-98% 15N] GABARAPL-1, 0.9 mM NBR1-LIR, 50 mM sodium phosphate, 100 mM sodium chloride, 4.6 mM sodium azide, 1 mM protease inhibitor cocktail, 0.3 mM DSS | 95% H2O/5% D2O | 0.1 | 7.0 | ambient | 298 | |
11 | 3D 1H-15N NOESY | 0.6 mM [U-98% 13C; U-98% 15N] GABARAPL-1, 0.9 mM NBR1-LIR, 50 mM sodium phosphate, 100 mM sodium chloride, 4.6 mM sodium azide, 1 mM protease inhibitor cocktail, 0.3 mM DSS | 95% H2O/5% D2O | 0.1 | 7.0 | ambient | 298 | |
12 | 3D 1H-13C NOESY | 0.6 mM [U-98% 13C; U-98% 15N] GABARAPL-1, 0.9 mM NBR1-LIR, 50 mM sodium phosphate, 100 mM sodium chloride, 4.6 mM sodium azide, 1 mM protease inhibitor cocktail, 0.3 mM DSS | 95% H2O/5% D2O | 0.1 | 7.0 | ambient | 298 | |
13 | TROSY-H(CCCO)NH-TOCSY | 0.6 mM [U-98% 13C; U-98% 15N] GABARAPL-1, 0.9 mM NBR1-LIR, 50 mM sodium phosphate, 100 mM sodium chloride, 4.6 mM sodium azide, 1 mM protease inhibitor cocktail, 0.3 mM DSS | 95% H2O/5% D2O | 0.1 | 7.0 | ambient | 298 | |
14 | (H)CC(CO)NH-TOCSY | 0.6 mM [U-98% 13C; U-98% 15N] GABARAPL-1, 0.9 mM NBR1-LIR, 50 mM sodium phosphate, 100 mM sodium chloride, 4.6 mM sodium azide, 1 mM protease inhibitor cocktail, 0.3 mM DSS | 95% H2O/5% D2O | 0.1 | 7.0 | ambient | 298 | |
15 | 3D HNCA | 0.9 mM GABARAPL-1, 0.6 mM [U-98% 13C; U-98% 15N] NBR1-LIR, 50 mM sodium phosphate, 100 mM sodium chloride, 4.6 mM sodium azide, 1 mM protease inhibitor cocktail, 0.3 mM DSS | 95% H2O/5% D2O | 0.1 | 7.0 | ambient | 298 | |
16 | 3D HNCACB | 0.9 mM GABARAPL-1, 0.6 mM [U-98% 13C; U-98% 15N] NBR1-LIR, 50 mM sodium phosphate, 100 mM sodium chloride, 4.6 mM sodium azide, 1 mM protease inhibitor cocktail, 0.3 mM DSS | 95% H2O/5% D2O | 0.1 | 7.0 | ambient | 298 | |
17 | 3D 1H-15N NOESY | 0.9 mM GABARAPL-1, 0.6 mM [U-98% 13C; U-98% 15N] NBR1-LIR, 50 mM sodium phosphate, 100 mM sodium chloride, 4.6 mM sodium azide, 1 mM protease inhibitor cocktail, 0.3 mM DSS | 95% H2O/5% D2O | 0.1 | 7.0 | ambient | 298 | |
18 | 3D 1H-13C NOESY | 0.9 mM GABARAPL-1, 0.6 mM [U-98% 13C; U-98% 15N] NBR1-LIR, 50 mM sodium phosphate, 100 mM sodium chloride, 4.6 mM sodium azide, 1 mM protease inhibitor cocktail, 0.3 mM DSS | 95% H2O/5% D2O | 0.1 | 7.0 | ambient | 298 | |
19 | 3D HCCH-TOCSY | 0.9 mM GABARAPL-1, 0.6 mM [U-98% 13C; U-98% 15N] NBR1-LIR, 50 mM sodium phosphate, 100 mM sodium chloride, 4.6 mM sodium azide, 1 mM protease inhibitor cocktail, 0.3 mM DSS | 95% H2O/5% D2O | 0.1 | 7.0 | ambient | 298 | |
20 | TROSY-H(CCCO)NH-TOCSY | 0.9 mM GABARAPL-1, 0.6 mM [U-98% 13C; U-98% 15N] NBR1-LIR, 50 mM sodium phosphate, 100 mM sodium chloride, 4.6 mM sodium azide, 1 mM protease inhibitor cocktail, 0.3 mM DSS | 95% H2O/5% D2O | 0.1 | 7.0 | ambient | 298 | |
21 | (H)CC(CO)NH-TOCSY | 0.9 mM GABARAPL-1, 0.6 mM [U-98% 13C; U-98% 15N] NBR1-LIR, 50 mM sodium phosphate, 100 mM sodium chloride, 4.6 mM sodium azide, 1 mM protease inhibitor cocktail, 0.3 mM DSS | 95% H2O/5% D2O | 0.1 | 7.0 | ambient | 298 | |